# Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department

> **NCT00765648** · PHASE4 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 226 (actual)

## Conditions studied

- Hypertensive Urgency

## Interventions

- **DRUG:** nicardipine intravenous
- **DRUG:** Labetalol

## Key facts

- **NCT ID:** NCT00765648
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2015-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765648, "Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00765648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*